These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15613407)

  • 1. Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess.
    Chan JL; Bullen J; Stoyneva V; Depaoli AM; Addy C; Mantzoros CS
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1618-24. PubMed ID: 15613407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency.
    Chan JL; Moschos SJ; Bullen J; Heist K; Li X; Kim YB; Kahn BB; Mantzoros CS
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1625-31. PubMed ID: 15613409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
    Chan JL; Wong SL; Mantzoros CS
    Clin Pharmacokinet; 2008; 47(11):753-64. PubMed ID: 18840030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration.
    Gavrila A; Chan JL; Miller LC; Heist K; Yiannakouris N; Mantzoros CS
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1047-54. PubMed ID: 15546902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a potent antiinflammatory effect of rosiglitazone.
    Mohanty P; Aljada A; Ghanim H; Hofmeyer D; Tripathy D; Syed T; Al-Haddad W; Dhindsa S; Dandona P
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2728-35. PubMed ID: 15181049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and the proinflammatory state associated with human obesity.
    Hukshorn CJ; Lindeman JH; Toet KH; Saris WH; Eilers PH; Westerterp-Plantenga MS; Kooistra T
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1773-8. PubMed ID: 15070944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
    Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
    Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay.
    Chan JL; Wong SL; Orlova C; Raciti P; Mantzoros CS
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2307-11. PubMed ID: 17405837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
    Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
    Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.
    Lee JH; Chan JL; Yiannakouris N; Kontogianni M; Estrada E; Seip R; Orlova C; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4848-56. PubMed ID: 14557464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.
    Ghanim H; Garg R; Aljada A; Mohanty P; Kumbkarni Y; Assian E; Hamouda W; Dandona P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1306-12. PubMed ID: 11238525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between body mass index and plasma adiponectin levels in healthy adults.
    Kuo SM; Halpern MM
    Int J Obes (Lond); 2011 Dec; 35(12):1487-94. PubMed ID: 21364526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects.
    Beilfuss J; Berg V; Sneve M; Jorde R; Kamycheva E
    Cytokine; 2012 Dec; 60(3):870-4. PubMed ID: 22925537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance training reduces subclinical inflammation in obese, postmenopausal women.
    Phillips MD; Patrizi RM; Cheek DJ; Wooten JS; Barbee JJ; Mitchell JB
    Med Sci Sports Exerc; 2012 Nov; 44(11):2099-110. PubMed ID: 22874536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker.
    Devaraj S; O'Keefe G; Jialal I
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4549-54. PubMed ID: 15899961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
    Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
    Hepatology; 2008 Jul; 48(1):80-7. PubMed ID: 18571785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial lipase is increased in vivo by inflammation in humans.
    Badellino KO; Wolfe ML; Reilly MP; Rader DJ
    Circulation; 2008 Feb; 117(5):678-85. PubMed ID: 18212282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women.
    Maachi M; Piéroni L; Bruckert E; Jardel C; Fellahi S; Hainque B; Capeau J; Bastard JP
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):993-7. PubMed ID: 15211360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.